Drug Type Gene therapy |
Synonyms- |
Target |
Mechanism PCSK9 modulators(Proprotein convertase subtilisin kexin type 9 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Chroma Medicine, Inc.Startup |
Active Organization Chroma Medicine, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypercholesterolemia | Preclinical | US | Chroma Medicine, Inc.Startup | 11 Nov 2023 |